Anemia Falciforme

MSC therapy for sickle cell anemia has shown potential in reducing episodes of pain, improving red blood cell function, and decreasing anemia-related fatigue. MSCs work by secreting growth factors that support the regeneration of blood cells and enhance bone marrow function. They also help reduce inflammation and oxidative stress, both of which play a significant role in sickle cell crises. MSCs have been shown to stimulate the production of healthy red blood cells, thereby improving overall blood oxygenation and reducing complications of sickle cell disease.


22. Thalassemia

In thalassemia, MSC therapy has led to improved hemoglobin levels, reduced blood transfusion dependence, and enhanced overall energy levels. MSCs promote hematopoiesis (produção de células sanguíneas) na medula óssea e pode reduzir a carga da anemia. Adicionalmente, MSCs ajudam na reparação de órgãos danificados, como o fígado e o baço, que são frequentemente afetados pela doença. Ao melhorar a produção de células sanguíneas, As MSCs podem melhorar a qualidade de vida geral dos pacientes com talassemia.


23. Hemofilia

As MSCs autólogas têm se mostrado promissoras no tratamento da hemofilia, melhorando a capacidade de coagulação e reduzindo episódios hemorrágicos. As MSCs exercem seus efeitos promovendo a reparação tecidual e modulando o sistema imunológico, melhorando a cura de vasos sanguíneos danificados. Eles também apoiam a regeneração das paredes dos vasos sanguíneos, reduzindo tendências de sangramento. Os efeitos parácrinos das CTM incluem a secreção de fatores que promovem a integridade vascular e melhoram o ambiente de coagulação, contribuindo para menos eventos hemorrágicos.


24. Osteoporose

MSC therapy for osteoporosis can improve bone density, reduzir o risco de fratura, and enhance overall skeletal health. MSCs work by promoting osteogenesis (formação óssea), increasing the production of bone-building cells (osteoblastos), and enhancing the mineralization of bone tissue. They also help reduce bone resorption (breakdown) by inhibiting osteoclast activity. MSCs improve the structural integrity of bones and prevent bone loss, making them a promising treatment option for osteoporosis patients.


25. Osteomielite

In cases of osteomyelitis, MSC therapy has been shown to help reduce bone inflammation, enhance bone healing, and improve infection resistance. MSCs promote tissue regeneration and stimulate the healing of bone and soft tissues by secreting anti-inflammatory cytokines and growth factors. They also enhance the formation of new blood vessels (angiogênese) in the infected bone, improving tissue oxygenation and facilitating faster recovery from infection.


26. Lesão na Medula Espinhal

MSC therapy for spinal cord injury has shown promising results in improving motor function, reducing paralysis, and enhancing sensory recovery. MSCs act by promoting neurogenesis, protecting neurons from damage, and stimulating the regeneration of spinal cord tissue. They also reduce the chronic inflammation that occurs after spinal injury, improving long-term recovery outcomes. By secreting neuroprotective factors, MSCs help restore the damaged neural circuits, leading to improved movement and sensory function.


27. Retinal Degeneration

In retinal degeneration, MSCs can improve vision, reduce retinal inflammation, and stimulate the regeneration of retinal cells. Os mecanismos de ação envolvem a secreção de fatores de crescimento que promovem a sobrevivência e regeneração das células da retina.. As MSCs ajudam a reduzir o estresse oxidativo e a inflamação, ambos contribuem para a degeneração da retina. Adicionalmente, As MSCs podem melhorar a formação de novos vasos sanguíneos na retina, melhorando a oxigenação da retina e prevenindo maiores perdas de visão.


28. Degeneração Macular Relacionada à Idade (AMD)

A terapia MSC para DMRI mostrou benefícios na melhoria da visão, reduzindo a atrofia da retina, e restaurar alguma função macular. As MSCs atuam secretando citocinas antiinflamatórias e fatores de crescimento que promovem a reparação e regeneração do tecido retinal. Eles ajudam a diminuir a formação de vasos sanguíneos anormais (neovascularização) na retina, que é uma característica chave da AMD. Ao melhorar os processos de reparação celular, As MSC contribuem para a preservação da visão e da saúde ocular em geral.


29. Glaucoma

O tratamento de MSC foi investigado para glaucoma, com resultados promissores na redução da pressão intraocular (PIO), melhorando a função do nervo óptico, e melhorando a acuidade visual. As MSCs atuam reduzindo a inflamação no nervo óptico e promovendo a regeneração das células ganglionares da retina. Eles também ajudam a melhorar o fluxo sanguíneo para o nervo óptico, o que é crucial para prevenir maiores danos em pacientes com glaucoma. Ao estimular a reparação celular e reduzir o stress oxidativo, As MSCs protegem as células da retina da degeneração e melhoram os resultados da visão.


30. Retinopatia Diabética

Demonstrou-se que as MSCs autólogas ajudam a reduzir o edema retiniano, melhorar a vascularização da retina, e preservar a visão na retinopatia diabética. As MSCs promovem a regeneração do tecido da retina e reduzem a inflamação no olho. They work by secreting growth factors that stimulate the formation of new blood vessels in the retina, improving oxygen supply to the affected areas. MSCs also protect retinal cells from oxidative damage, which is a major contributor to diabetic retinopathy.


31. Tipo 1 Diabetes

MSC therapy for type 1 diabetes has shown potential in reducing insulin dependency, improving blood glucose control, and protecting pancreatic beta cells. MSCs help by modulating the immune response, reducing the autoimmune attack on beta cells, e promovendo a reparação tecidual. They secrete anti-inflammatory cytokines and growth factors that aid in the regeneration of beta cells in the pancreas, potentially restoring insulin production and improving metabolic control.


32. Tipo 2 Diabetes

In type 2 diabetes, MSC therapy has been shown to improve insulin sensitivity, reduce blood sugar levels, and enhance metabolic function. MSCs work by promoting the regeneration of pancreatic beta cells, improving insulin secretion, e reduzindo a inflamação. Adicionalmente, MSCs enhance the function of insulin-sensitive tissues such as muscle and liver, helping to restore normal glucose metabolism. By reducing systemic inflammation, MSCs also contribute to improved cardiovascular health in type 2 diabetes patients.


33. Cystic Fibrosis

MSC therapy in cystic fibrosis has shown improvements in lung function, reduced mucus buildup, and enhanced overall respiratory health. MSCs work by reducing inflammation in the lungs, promovendo a reparação tecidual, and stimulating the regeneration of damaged epithelial cells. They secrete anti-inflammatory cytokines that help reduce the chronic lung inflammation characteristic of cystic fibrosis. Adicionalmente, MSCs support the repair of the damaged lung tissue, improving airway function and reducing exacerbations.


34. Asma

MSC therapy has been investigated for asthma, with promising results in reducing airway inflammation, melhorando a função pulmonar, and reducing the frequency of asthma attacks. MSCs help by modulating the immune response, reducing the production of pro-inflammatory cytokines, and enhancing the repair of damaged airway tissue. They also improve mucosal healing in the lungs and promote the regeneration of epithelial cells, leading to better airflow and reduced asthma symptoms.


35. Pulmonary Hypertension

MSC infusion has been shown to improve exercise capacity, reduce pulmonary artery pressure, and enhance overall lung function in pulmonary hypertension. MSCs work by promoting the regeneration of damaged blood vessels, improving blood flow, and reducing pulmonary vascular resistance. They also reduce inflammation in the pulmonary vasculature and secrete growth factors that stimulate endothelial cell proliferation and angiogenesis. These effects contribute to improved cardiac and respiratory function in pulmonary hypertension patients.


36. Chronic Sinusitis

In chronic sinusitis, MSC therapy can reduce inflammation, improve nasal airflow, and reduce the frequency of sinus infections. MSCs act by reducing inflammation in the sinus mucosa, promovendo a reparação tecidual, and enhancing immune regulation. They secrete anti-inflammatory cytokines that help reduce chronic swelling and irritation in the sinuses. By stimulating tissue regeneration and improving blood flow, MSCs contribute to better sinus function and fewer episodes of infection.


37. Endometriose

MSC therapy in endometriosis has shown benefits in reducing pelvic pain, improving fertility, and reducing the size of endometrial lesions. MSCs exert their effects by modulating the immune system, reduzindo a inflamação, e promovendo a regeneração dos tecidos. They help reduce the formation of adhesions and improve the healing of damaged tissues. Adicionalmente, MSCs secrete growth factors that support the repair of the damaged reproductive organs, contributing to improved fertility and pain reduction.


38. Polycystic Ovary Syndrome (SOP)

In PCOS, MSC therapy has shown potential in improving ovarian function, reducing cyst formation, and enhancing fertility. MSCs work by promoting tissue repair, reducing ovarian inflammation, and enhancing the production of healthy eggs. They help regulate hormone levels, reduce insulin resistance, and improve the function of the ovaries. By enhancing ovarian health and improving the hormonal balance, MSCs contribute to better fertility outcomes for women with PCOS.


39. Endometrial Atrophy

MSC therapy for endometrial atrophy has shown promise in improving uterine lining thickness, restoring fertility, and reducing pelvic discomfort. MSCs promote the regeneration of the endometrial tissue, improving its structure and function. They also reduce inflammation in the uterus, which contributes to the restoration of normal menstrual cycles. By stimulating tissue repair and improving the uterine environment, MSCs help enhance reproductive health and fertility.


40. Disfunção erétil

MSC therapy for erectile dysfunction has shown potential in improving erectile function, increasing libido, and enhancing sexual performance. MSCs help by promoting tissue regeneration in the erectile tissue, improving blood flow, e reduzindo a inflamação. They secrete growth factors that enhance the formation of new blood vessels, improving penile circulation and function. By promoting tissue repair and enhancing vascular health, MSCs offer a promising treatment option for erectile dysfunction.

Consultor de pesquisa científica

Interessado em saber se os programas clínicos atuais, desenvolvimentos de pesquisa, ou abordagens terapêuticas emergentes podem ser relevantes para a sua situação?

Apenas informações educacionais e de pesquisa. As decisões médicas individuais devem ser tomadas em consulta com profissionais de saúde qualificados.


NBSciência

organização de pesquisa contratada

WhatsApp